Home › Plasma Cell Cancer › Massachusetts › Boston

Plasma Cell Cancer clinical trials in Boston, MA

5 studies for Plasma Cell Cancer are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

RecruitingPhase 3

Beth Israel Deaconess Medical Center, Boston
BIDMC Research Pharmacy, Boston

Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06152575

ELEVATE-MM: Elotuzumab, Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

RecruitingPhase 1

Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06518551

HEME Home Transfusion Program

Recruiting

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06487247

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

RecruitingPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT05651932

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

RecruitingPhase 4

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07426484

Plasma Cell Cancer trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.